BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38697654)

  • 1. Building, Breaking, and Repairing Neuromuscular Synapses.
    Herbst R; Huijbers MG; Oury J; Burden SJ
    Cold Spring Harb Perspect Biol; 2024 May; 16(5):. PubMed ID: 38697654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and activation of MuSK, a receptor tyrosine kinase central to neuromuscular junction formation.
    Hubbard SR; Gnanasambandan K
    Biochim Biophys Acta; 2013 Oct; 1834(10):2166-9. PubMed ID: 23467009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MuSk function during health and disease.
    Herbst R
    Neurosci Lett; 2020 Jan; 716():134676. PubMed ID: 31811897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
    Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
    Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
    Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
    Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agrin/Lrp4 signal constrains MuSK-dependent neuromuscular synapse development in appendicular muscle.
    Walker LJ; Roque RA; Navarro MF; Granato M
    Development; 2021 Nov; 148(21):. PubMed ID: 34714331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
    Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
    PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural mechanisms of the agrin-LRP4-MuSK signaling pathway in neuromuscular junction differentiation.
    Zong Y; Jin R
    Cell Mol Life Sci; 2013 Sep; 70(17):3077-88. PubMed ID: 23178848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into the assembly of the agrin/LRP4/MuSK signaling complex.
    Xie T; Xu G; Liu Y; Quade B; Lin W; Bai XC
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2300453120. PubMed ID: 37252960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New dogs in the dogma: Lrp4 and Tid1 in neuromuscular synapse formation.
    Song Y; Balice-Gordon R
    Neuron; 2008 Nov; 60(4):526-8. PubMed ID: 19038209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).
    Zhang W; Coldefy AS; Hubbard SR; Burden SJ
    J Biol Chem; 2011 Nov; 286(47):40624-30. PubMed ID: 21969364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular region of Lrp4 is sufficient to mediate neuromuscular synapse formation.
    Gomez AM; Burden SJ
    Dev Dyn; 2011 Dec; 240(12):2626-33. PubMed ID: 22038977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRP4 serves as a coreceptor of agrin.
    Zhang B; Luo S; Wang Q; Suzuki T; Xiong WC; Mei L
    Neuron; 2008 Oct; 60(2):285-97. PubMed ID: 18957220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders.
    Ohno K; Ohkawara B; Ito M
    Expert Opin Ther Targets; 2017 Oct; 21(10):949-958. PubMed ID: 28825343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lrp4 is a receptor for Agrin and forms a complex with MuSK.
    Kim N; Stiegler AL; Cameron TO; Hallock PT; Gomez AM; Huang JH; Hubbard SR; Dustin ML; Burden SJ
    Cell; 2008 Oct; 135(2):334-42. PubMed ID: 18848351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease.
    Ding Q; Kesavan K; Lee KM; Wimberger E; Robertson T; Gill M; Power D; Chang J; Fard AT; Mar JC; Henderson RD; Heggie S; McCombe PA; Jeffree RL; Colditz MJ; Hilliard MA; Ng DCH; Steyn FJ; Phillips WD; Wolvetang EJ; Ngo ST; Noakes PG
    Acta Neuropathol Commun; 2022 Apr; 10(1):61. PubMed ID: 35468848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
    Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple MuSK signaling pathways and the aging neuromuscular junction.
    Fish LA; Fallon JR
    Neurosci Lett; 2020 Jul; 731():135014. PubMed ID: 32353380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia.
    Oury J; Zhang W; Leloup N; Koide A; Corrado AD; Ketavarapu G; Hattori T; Koide S; Burden SJ
    Nature; 2021 Jul; 595(7867):404-408. PubMed ID: 34163073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel pathway for MuSK to induce key genes in neuromuscular synapse formation.
    Lacazette E; Le Calvez S; Gajendran N; Brenner HR
    J Cell Biol; 2003 May; 161(4):727-36. PubMed ID: 12756238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.